The landscape of dementia prognosis has developed considerably with the arrival of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades right before signs or symptoms emerge. Whilst these technological advances stand for impressive progress in understanding neurodegenerative health conditions, https://neuropsychological-testin45443.bloginwi.com/71684724/the-enduring-price-of-cognitive-evaluation-for-older-older-people